These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23668371)
1. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib. Tamilvanan S; Baskar R Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371 [TBL] [Abstract][Full Text] [Related]
2. Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions. Tamilvanan S; Kumar BA Drug Dev Ind Pharm; 2011 Sep; 37(9):1003-15. PubMed ID: 21417616 [TBL] [Abstract][Full Text] [Related]
3. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111 [TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion. Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of transdermal patches of celecoxib. Alam MI; Baboota S; Kohli K; Ali J; Ahuja A PDA J Pharm Sci Technol; 2009; 63(5):429-37. PubMed ID: 20158049 [TBL] [Abstract][Full Text] [Related]
6. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Shakeel F; Faisal MS Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. Quiñones OG; Mata dos Santos HA; Kibwila DM; Leitão A; dos Santos Pyrrho A; Pádula Md; Rosas EC; Lara MG; Pierre MB Drug Dev Ind Pharm; 2014 Sep; 40(9):1180-9. PubMed ID: 23826859 [TBL] [Abstract][Full Text] [Related]
8. Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation. Fetih G; Fathalla D; El-Badry M Drug Dev Res; 2014 Jun; 75(4):257-66. PubMed ID: 24939834 [TBL] [Abstract][Full Text] [Related]
9. Topical delivery of celecoxib using microemulsion. Subramanian N; Ghosal SK; Moulik SP Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689 [TBL] [Abstract][Full Text] [Related]
10. Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery. Jin SG; Yousaf AM; Son MW; Jang SW; Kim DW; Kim JO; Yong CS; Kim JH; Choi HG Arch Pharm Res; 2015 Feb; 38(2):216-22. PubMed ID: 24988989 [TBL] [Abstract][Full Text] [Related]
11. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Kaur K; Jain S; Sapra B; Tiwary AK Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648 [TBL] [Abstract][Full Text] [Related]
12. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies. Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729 [TBL] [Abstract][Full Text] [Related]
13. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Subramanian N; Ghosal SK; Moulik SP Drug Dev Ind Pharm; 2005 May; 31(4-5):405-16. PubMed ID: 16093206 [TBL] [Abstract][Full Text] [Related]
14. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch. Kalita B; Das MK; Sarma M; Deka A AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988 [TBL] [Abstract][Full Text] [Related]
15. The analgesic and anti-inflammatory effect of WIN-34B, a new herbal formula for osteoarthritis composed of Lonicera japonica Thunb and Anemarrhena asphodeloides BUNGE in vivo. Kang M; Jung I; Hur J; Kim SH; Lee JH; Kang JY; Jung KC; Kim KS; Yoo MC; Park DS; Lee JD; Cho YB J Ethnopharmacol; 2010 Sep; 131(2):485-96. PubMed ID: 20643199 [TBL] [Abstract][Full Text] [Related]
16. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525 [TBL] [Abstract][Full Text] [Related]
17. Studies on ocular and parenteral application potentials of azithromycin- loaded anionic, cationic and neutral-charged emulsions. Tamilvanan S; Khanum R; Senthilkumar SR; Muthuraman M; Rajasekharan T Curr Drug Deliv; 2013 Oct; 10(5):572-86. PubMed ID: 23721117 [TBL] [Abstract][Full Text] [Related]
18. Mometasone furoate-loaded cold processed oil-in-water emulsions: in vitro and in vivo studies. Raposo S; Tavares R; Gonçalves L; Simões S; Urbano M; Ribeiro HM Drug Deliv; 2015; 22(4):562-72. PubMed ID: 24559480 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Tang SY; Sivakumar M; Ng AM; Shridharan P Int J Pharm; 2012 Jul; 430(1-2):299-306. PubMed ID: 22503988 [TBL] [Abstract][Full Text] [Related]
20. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies. Estracanholli EA; Praça FS; Cintra AB; Pierre MB; Lara MG AAPS PharmSciTech; 2014 Dec; 15(6):1468-75. PubMed ID: 24980082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]